Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Sudden cardiac death secondary to antidepressant and antipsychotic drugs.

Expert opinion on drug safety - 1 Mar 2008

Sicouri Serge, Antzelevitch Charles

Abstract excerpt

A number of antipsychotic and antidepressant drugs are known to increase the risk of ventricular arrhythmias and sudden cardiac death. Based largely on a concern over QT prolongation and the development of life-threatening arrhythmias, a number of antipsychotic drugs have been temporarily or permanently withdrawn from the market or their use restricted. Some antidepressants and antipsychotics have been linked to...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antidepressive Agents
Share to Antipsychotic Agents
Share to Brugada Syndrome

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Death, Sudden, Cardiac

Share to Ion Channels

Share to Long QT Syndrome

Share to Risk Factors

Share to Torsades de Pointes

Source

Open in PubMed Open full text

Identifiers

PMID: 18324881
DOI: 10.1517/14740338.7.2.181
PMCID: PMC2365731

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Sudden cardiac death secondary to antidepressant and antipsychotic drugs.PMID 18324881Read ↗

Antipsychotic-related QTc prolongation, torsade de pointes and sudden death.Semantic proximity Read ↗

Drug-induced proarrhythmia: risk factors and electrophysiological mechanisms.Semantic proximity Read ↗

Drug-induced Brugada syndrome by noncardiac agents.Semantic proximity Read ↗

Drug-induced fatal arrhythmias: Acquired long QT and Brugada syndromesSemantic proximity Read ↗

Drug‐ and non‐drug‐associated QT interval prolongationSemantic proximity Read ↗

Effect of long-term combined use of antipsychotics on ventricular repolarization indexSemantic proximity Read ↗

Dangerous and life-threatening drugs - practical lessons from the long QT syndrome.Semantic proximity Read ↗

The genetics of pro-arrhythmic adverse drug reactions.Semantic proximity Read ↗

Molecular predictors of drug-induced prolongation of the QT interval.Semantic proximity Read ↗

Cardiovascular drugs inducing QT prolongation: facts and evidence.Semantic proximity Read ↗

Drug-induced arrhythmia: pharmacogenomic prescribing?Semantic proximity Read ↗

QT interval prolongation and cardiac risk assessment for novel drugs.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.